A REVIEW ARTICLE ON SCHEDULED DRUGS IN RETAIL PHARMACY

K. Neelaveni*, M. Sangeetha, Dr. J. Lavanya, B. Swapna and B. Gayatri Devi

ABSTRACT

Background: In the Drug and Cosmetics Rules, the drugs that stated under the Schedule H, Schedule X and Schedule G are needed to be sold by the retail on the prescription of a Registered Medical Practitioner only. Currently Schedule H and Schedule X contain 510 and 15 Drugs, subsequently. The new Schedule H1 has introduced that involves specifically 3rd and 4th generation Antibiotics, specific habit forming drugs and Anti-Tubercular Drugs. The prime objective of Scheduling system is to secure significant access to medicines during balancing public health and safety the schedule drugs which are sold across India are analysed by drug database pharmaTrac. Among 1600 regularly prescribed medicines, barely 656 are presently enclosed under the four Schedules (Schedule H, H1 Schedule X and Schedule G). But only 50% of the pharmacists were aware of schedules. Efforts are taken to reduce opioid related misuse of schedule X. prescribed drug monitoring program (PDMPs) which allows health care providers to access prescription history information to identify patients at risk for addiction. For antibiotics, the patterns of resistance are developed and as a result there classification needs to be re-evaluated on regular basis. In spite of some loopholes, online pharmacy has tremendously increased the sale of schedule drugs. Conclusion: It lays a strong foundation for re-evaluating the current drug schedule system. It also fills some of the major gaps in terms of drug classification and its implication. Building further on this work and developing robust process recommendations and technology based suggestions for implementing a more robust drug schedule system in the dynamic and complex Indian healthcare environment is considered.

Keywords: Dispensing, schedules update, drugs and cosmetics act amendments, monitoring drug schedule system, PDMPS.